Freestone Grove Partners LP Becton Dickinson & CO Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Becton Dickinson & CO stock. As of the latest transaction made, Freestone Grove Partners LP holds 439,138 shares of BDX stock, worth $98.9 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
439,138Holding current value
$98.9 Million% of portfolio
1.22%Shares
1 transactions
Others Institutions Holding BDX
# of Institutions
1,798Shares Held
260MCall Options Held
1.27MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$6.02 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5.01 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$3.17 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.78 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.73 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $64.2B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...